Statistics for Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing
Total visits
| views | |
|---|---|
| Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing | 88 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1540732.pdf | 81 |
| java.util.UUID:20cbe2ae-774c-433f-99ad-104a663b3c02 | 6 |
| java.util.UUID:67b5c45f-933e-4bed-9c55-6991be23114e | 1 |
| java.util.UUID:c7d792e1-f8c4-4b56-8d75-1c7d43db7736 | 1 |
Top country views
| views | |
|---|---|
| United States | 68 |
| China | 3 |
| Canada | 2 |
| Germany | 2 |
| Kazakhstan | 1 |
| Malaysia | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 40 |
| Houston | 7 |
| Cambridge | 5 |
| Fairfield | 3 |
| Beijing | 2 |
| Toronto | 2 |
| Almaty | 1 |
| Ann Arbor | 1 |
| Baltimore | 1 |
| Gunzenhausen | 1 |
| Jacksonville | 1 |
| Kiev | 1 |
| Kiez | 1 |
| San Francisco | 1 |
| Seremban | 1 |
| Zhongyuan | 1 |